Market Cap (In INR)
166.22 Billion
Revenue (In INR)
61.12 Billion
Net Income (In INR)
6.15 Billion
Avg. Volume
7013.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 744.95-1296.15
- PE
- 27.56
- EPS
- 30.68
- Beta Value
- 0.691
- ISIN
- INE901L01018
- CUSIP
- -
- CIK
- -
- Shares
- 196563000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Chirayu Ramanbhai Amin
- Employee Count
- -
- Website
- https://alembicpharmaceuticals.com
- Ipo Date
- 2011-09-20
- Details
- Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.
More Stocks
-
DLG
-
FHGDFFounder Holdings Limited
FHGDF
-
KENS
-
0JSZLadder Capital Corp
0JSZ
-
601699
-
NEA
-
RIGHBud Genius, Inc.
RIGH
-
FL